|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| 09-27 | The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 05-21 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| Market Cap | 3.26B 62.29M 55.63M 51.9M 47.14M 88.71M 6.03B 89.57M 623M 244M 3.07B 234M 229M 9.86B | P/E 2025 |
6.08x | P/E 2026 | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.7B 70.7M 63.14M 58.9M 53.5M 101M 6.85B 102M 707M 277M 3.48B 265M 260M 11.19B | EV / Sales 2025 |
1.47x | EV / Sales 2026 | 2.43x |
| Free-Float |
18.09% | Yield 2025 |
4.14% | Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.81% | +0.39% | +36.49% | +101.89% | 1,060B | |
| -1.12% | -1.19% | +34.74% | +61.21% | 623B | |
| -0.44% | +4.09% | +17.01% | +81.46% | 480B | |
| -1.09% | -1.79% | +63.46% | +35.15% | 352B | |
| -2.03% | +1.06% | +21.08% | +40.60% | 345B | |
| -1.92% | -0.29% | +10.54% | +33.58% | 274B | |
| -2.36% | -1.16% | -7.14% | +9.54% | 249B | |
| -1.82% | -0.24% | +37.90% | +49.63% | 223B | |
| -0.26% | -0.65% | +23.92% | +95.23% | 182B | |
| Average | -1.53% | -0.48% | +26.44% | +56.48% | 420.89B | |
| Weighted average by Cap. | -1.72% | +0.04% | +29.57% | +66.40% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.12B 21.34M 19.06M 17.78M 16.15M 30.39M 2.07B 30.68M 213M 83.48M 1.05B 80.12M 78.38M 3.38B | 1.37B 26.15M 23.35M 21.79M 19.79M 37.24M 2.53B 37.6M 262M 102M 1.29B 98.19M 96.05M 4.14B |
| Net income | 228M 4.35M 3.88M 3.62M 3.29M 6.19M 421M 6.25M 43.49M 17.01M 214M 16.33M 15.97M 688M | 265M 5.05M 4.51M 4.21M 3.82M 7.19M 489M 7.26M 50.53M 19.76M 249M 18.97M 18.56M 800M |
| Net Debt | 433M 8.26M 7.38M 6.88M 6.25M 11.76M 800M 11.88M 82.63M 32.32M 407M 31.02M 30.34M 1.31B | 441M 8.41M 7.51M 7M 6.36M 11.97M 814M 12.09M 84.09M 32.89M 414M 31.57M 30.88M 1.33B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
